Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction
They called the 2020 crash 45 days early. Nobody expects what they're predicting now...
View this shocking prediction now

PDLI Insider Trading (PDL BioPharma)

Insider Ownership Percentage: 2.20%
Insider Buying (Last 12 Months): $12,732,329.48
Insider Selling (Last 12 Months): $2,891,728.14

PDL BioPharma Insider Trading History Chart

PDL BioPharma Share Price & Price History

+0.30 (1.20%)
As of 02/26/2021 01:00 AM ET
Days: 30 | 90 | 365
30-Days of MarketBeat All Access for $1.00 (February Sale!)
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Just $1.00 for 30 days.
Start Your Risk-Free Trial Here

PDL BioPharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/30/2020David W GryskaDirectorSell20,000$2.74$54,800.001,387  
12/29/2020Silver Point Capital L.P.Major ShareholderBuy631,600$2.69$1,699,004.00  
12/23/2020Silver Point Capital L.P.Major ShareholderBuy1,565,000$2.60$4,069,000.0015,491,460  
12/21/2020John Peter MclaughlinDirectorSell50,000$2.62$131,000.00477,934  
12/21/2020Silver Point Capital L.P.Major ShareholderBuy230,000$2.63$604,900.0015,491,460  
12/16/2020Christopher Lewis StoneVPSell200,000$2.56$512,000.00405,559  
12/16/2020David W GryskaDirectorSell75,000$2.68$201,000.0021,387  
12/16/2020Dominique MonnetCEOSell500,000$2.60$1,300,000.00734,921  
12/16/2020Silver Point Capital L.P.Major ShareholderBuy1,350,000$2.58$3,483,000.0014,863,460  
12/14/2020Silver Point Capital L.P.Major ShareholderBuy640,000$2.62$1,676,800.00  
12/11/2020Silver Point Capital L.P.Major ShareholderBuy450,000$2.45$1,102,500.00  
12/3/2020David W GryskaDirectorSell75,000$2.52$189,000.0030,337  
11/23/2020Elizabeth G. O'farrellDirectorSell25,826$2.44$63,015.44105,337  
11/20/2020Alan Lee BazaarDirectorSell33,435$2.42$80,912.7070,515  
11/18/2020David W GryskaDirectorSell150,000$2.40$360,000.00145,337  
9/29/2020Pdl Biopharma, Inc.Major ShareholderBuy8,703$11.16$97,125.488,667,397  
6/10/2019Pdl Biopharma, Inc.Major ShareholderBuy6,666,667$4.50$30,000,001.5013,333,334  
See Full Table

SEC Filings (Institutional Ownership Changes) for PDL BioPharma (NASDAQ:PDLI)

86.17% of PDL BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

PDL BioPharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/16/2021Park West Asset Management LLC14,397,212$35.56M0.7%+56.9%12.604%
2/11/2021Eqis Capital Management Inc.54,735$0.14M0.0%-21.1%0.048%
2/11/2021JBF Capital Inc.543,990$1.34M0.2%+260.8%0.476%
2/10/2021KBC Group NV79,332$0.20M0.0%+35.7%0.069%
2/9/2021Hancock Whitney Corp187,757$0.46M0.0%+28.6%0.164%
2/8/2021Russell Investments Group Ltd.196,783$0.49M0.0%-76.3%0.172%
2/5/2021GABELLI & Co INVESTMENT ADVISERS INC.633,700$1.57M0.2%N/A0.555%
2/5/2021Gabelli Funds LLC512,534$1.27M0.0%N/A0.449%
2/1/2021Victory Capital Management Inc.17,605$43K0.0%-92.0%0.015%
1/19/2021FNY Investment Advisers LLC100,000$0.25M0.1%N/A0.088%
11/17/2020Paloma Partners Management Co135,953$0.43M0.0%N/A0.119%
11/17/2020Silver Point Capital L.P.6,424,000$20.24M2.5%+31.1%5.636%
11/17/2020Jane Street Group LLC58,463$0.18M0.0%-72.8%0.051%
11/16/2020AQR Capital Management LLC262,907$0.83M0.0%-72.4%0.231%
11/16/2020Context Capital Management LLC465,172$1.47M0.3%-33.6%0.408%
11/16/2020Squarepoint Ops LLC40,402$0.13M0.0%-42.8%0.035%
11/16/2020ExodusPoint Capital Management LP40,158$0.13M0.0%+223.0%0.035%
11/13/2020Morgan Stanley26,918$86K0.0%-79.5%0.024%
11/13/2020Charles Schwab Investment Management Inc.2,042,988$6.44M0.0%-12.0%1.792%
11/12/2020JBF Capital Inc.150,778$0.48M0.1%+197.2%0.132%
11/12/2020Brandes Investment Partners LP4,723,376$14.88M0.5%-11.7%4.144%
11/12/2020Connor Clark & Lunn Investment Management Ltd.2,167,755$6.83M0.0%-27.0%1.902%
11/12/2020Arrowstreet Capital Limited Partnership1,293,289$4.07M0.0%+68.2%1.135%
11/12/2020Federated Hermes Inc.360,775$1.14M0.0%-14.5%0.317%
11/10/2020State Street Corp5,268,663$16.60M0.0%-11.8%4.622%
11/10/2020Eqis Capital Management Inc.69,409$0.22M0.0%-12.8%0.061%
11/9/2020SG Americas Securities LLC21,294$67K0.0%-25.2%0.019%
11/9/2020Fuller & Thaler Asset Management Inc.1,129,470$3.56M0.0%-4.8%0.991%
11/9/2020Victory Capital Management Inc.220,517$0.70M0.0%+6.7%0.193%
11/6/2020BlackRock Inc.9,813,602$30.91M0.0%-1.5%8.610%
11/6/2020Aperio Group LLC123,000$0.39M0.0%+19.2%0.108%
11/5/2020California Public Employees Retirement System265,661$0.84M0.0%+5.9%0.233%
11/5/2020Alps Advisors Inc.145,354$0.46M0.0%-8.6%0.128%
11/5/2020Wells Fargo & Company MN389,952$1.23M0.0%-70.6%0.342%
11/4/2020Alps Advisors Inc.145,354$0.46M0.0%-8.6%0.128%
11/4/2020SMH Capital Advisors Inc.162,336$0.51M1.2%-98.3%0.142%
10/30/2020BNP Paribas Arbitrage SA32,581$0.10M0.0%+130.3%0.029%
10/30/2020WINTON GROUP Ltd574,423$1.81M0.1%-31.9%0.504%
10/29/2020DekaBank Deutsche Girozentrale50,100$0.16M0.0%N/A0.044%
10/28/2020KBC Group NV58,461$0.17M0.0%-39.5%0.051%
10/27/2020State of New Jersey Common Pension Fund D685,404$2.16M0.0%-10.9%0.601%
10/23/2020Deltec Asset Management LLC50,000$0.16M0.0%N/A0.044%
10/20/2020Nisa Investment Advisors LLC13,050$41K0.0%N/A0.011%
10/16/2020Bellecapital International Ltd.108,025$0.32M0.1%N/A0.095%
9/4/2020Principal Financial Group Inc.12,966$38K0.0%-88.8%0.011%
8/20/2020Charles Schwab Investment Management Inc.2,322,843$6.76M0.0%-20.7%2.038%
8/18/2020Engine Capital Management LP2,676,850$7.79M5.1%-15.3%2.348%
8/17/2020Zebra Capital Management LLC71,071$0.21M0.3%-3.9%0.062%
8/17/2020AQR Capital Management LLC953,865$2.78M0.0%-30.8%0.837%
8/17/2020Jane Street Group LLC214,559$0.62M0.0%N/A0.188%
8/17/2020Public Employees Retirement System of Ohio27,771$81K0.0%-15.4%0.024%
8/14/2020Tudor Investment Corp Et Al53,301$0.16M0.0%-32.9%0.047%
8/14/2020Ancora Advisors LLC1,693,216$4.93M0.2%-4.7%1.486%
8/13/2020Federated Hermes Inc.422,069$1.23M0.0%-3.6%0.370%
8/13/2020Archetype Wealth Partners LLC34,000$37K0.0%N/A0.030%
8/13/2020Grantham Mayo Van Otterloo & Co. LLC1,107,900$3.22M0.0%+11.4%0.972%
8/12/2020Bank of Montreal Can12,499$35K0.0%+725.6%0.011%
8/12/2020Goldman Sachs Group Inc.1,452,856$4.23M0.0%+540.8%1.275%
8/12/2020Brandes Investment Partners LP5,351,132$15.57M0.5%-6.7%4.696%
8/12/2020West Family Investments Inc.539,450$1.75M0.4%-13.7%0.473%
8/12/2020Prudential Financial Inc.680,071$1.98M0.0%N/A0.597%
8/11/2020Context Capital Management LLC700,172$2.04M0.8%N/A0.614%
8/10/2020Eqis Capital Management Inc.79,590$0.23M0.0%-8.0%0.070%
8/7/2020Rafferty Asset Management LLC50,412$0.15M0.0%N/A0.044%
8/5/2020Principal Financial Group Inc.12,966$38K0.0%-88.8%0.011%
8/5/2020Alps Advisors Inc.158,981$0.46M0.0%-23.4%0.140%
8/5/2020JBF Capital Inc.50,725$0.15M0.0%N/A0.045%
8/5/2020Russell Investments Group Ltd.706,384$2.05M0.0%+4.0%0.620%
8/5/2020Swiss National Bank242,200$0.71M0.0%+8.9%0.213%
8/5/2020WINTON GROUP Ltd842,950$2.45M0.1%+32.3%0.740%
8/3/2020ProShare Advisors LLC34,072$99K0.0%+52.7%0.030%
7/31/2020UBS Group AG81,695$0.24M0.0%-39.0%0.072%
7/30/2020Hancock Whitney Corp143,377$0.42M0.0%-26.1%0.126%
7/24/2020Dupont Capital Management Corp47,941$0.14M0.0%-41.4%0.042%
7/23/2020Strs Ohio173,200$0.50M0.0%+9.0%0.152%
7/23/2020XTX Markets LLC14,699$43K0.1%N/A0.013%
7/21/2020Westside Investment Management Inc.500$1.46M0.0%-98.6%0.000%
7/20/2020SG Americas Securities LLC28,465$83K0.0%-58.4%0.025%
6/19/2020State Street Corp3,156,957$8.90M0.0%-4.5%2.709%
6/16/2020Royal Bank of Canada60,923$0.17M0.0%-14.1%0.052%
5/22/2020Madison Avenue Partners LP1,365,408$3.85M1.8%N/A1.172%
5/18/2020Zebra Capital Management LLC73,950$0.21M0.3%-9.6%0.063%
5/18/2020Mercer Global Advisors Inc. ADV79,289$0.22M0.0%-4.5%0.068%
5/18/2020Engine Capital Management LP3,161,163$10.97M5.7%-49.0%2.712%
5/15/2020AQR Capital Management LLC1,379,387$3.89M0.0%-38.3%1.184%
5/15/2020Invesco Ltd.639,091$1.80M0.0%-29.9%0.548%
5/15/2020Tudor Investment Corp Et Al79,424$0.22M0.0%-30.2%0.068%
5/15/2020Morgan Stanley265,843$0.75M0.0%-90.5%0.228%
5/14/2020Silver Point Capital L.P.4,900,000$13.82M1.6%N/A4.204%
5/14/2020Mackenzie Financial Corp24,950$70K0.0%N/A0.021%
5/14/2020Geode Capital Management LLC1,714,587$4.84M0.0%+3.9%1.462%
5/14/2020Legal & General Group Plc27,872$79K0.0%-18.0%0.024%
5/14/2020Deutsche Bank AG97,647$0.28M0.0%-99.1%0.083%
5/14/2020Grantham Mayo Van Otterloo & Co. LLC994,300$2.80M0.0%-12.2%0.848%
5/14/2020Nuveen Asset Management LLC508,719$1.44M0.0%-3.0%0.434%
5/13/2020Parametric Portfolio Associates LLC360,230$1.02M0.0%-34.4%0.307%
5/13/2020Kestrel Investment Management Corp871,300$2.46M1.9%N/A0.743%
5/13/2020Connor Clark & Lunn Investment Management Ltd.3,735,686$10.54M0.1%-6.8%3.185%
Data available starting January 2016

See Full Table
PDL BioPharma logo
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
Read More

Today's Range

Now: $2.47

50 Day Range

MA: $2.47

52 Week Range

Now: $2.47



Average Volume

1,480,534 shs

Market Capitalization

$282.14 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of PDL BioPharma?

PDL BioPharma's top insider investors include:
  1. Silver Point Capital LP (Major Shareholder)
  2. Pdl Biopharma, Inc (Major Shareholder)
  3. Dominique Monnet (CEO)
  4. John Peter Mclaughlin (Director)
  5. Christopher Lewis Stone (VP)
  6. David W Gryska (Director)
  7. Elizabeth G O'farrell (Director)
  8. Alan Lee Bazaar (Director)

Who are the major institutional investors of PDL BioPharma?

PDL BioPharma's top institutional shareholders include:
  1. Park West Asset Management LLC — 12.60%
  3. JBF Capital Inc. — 0.48%
  4. Gabelli Funds LLC — 0.45%
  5. Russell Investments Group Ltd. — 0.17%
  6. Hancock Whitney Corp — 0.16%

Which major investors are selling PDL BioPharma stock?

During the previous quarter, PDLI stock was sold by these institutional investors:
  1. Russell Investments Group Ltd.
  2. Victory Capital Management Inc.
  3. Eqis Capital Management Inc.
Within the last year, company insiders that have sold PDL BioPharma company stock include:
  1. Silver Point Capital LP (Major Shareholder)
  2. Pdl Biopharma, Inc (Major Shareholder)
  3. Dominique Monnet (CEO)
  4. John Peter Mclaughlin (Director)
  5. Christopher Lewis Stone (VP)
  6. David W Gryska (Director)

Which major investors are buying PDL BioPharma stock?

During the previous quarter, PDLI stock was purchased by institutional investors including:
  1. Park West Asset Management LLC
  3. Gabelli Funds LLC
  4. JBF Capital Inc.
  5. FNY Investment Advisers LLC
  6. Hancock Whitney Corp
  7. KBC Group NV
During the last year, these company insiders have bought PDL BioPharma stock:
  1. Silver Point Capital LP (Major Shareholder)
  2. Pdl Biopharma, Inc (Major Shareholder)
The END of Capitalism As We Know It?
A terrifying (for some) and new disruptive force is creating thousands of new millionaires (Barron’s reports 20,000 to 200,000 so far) while at the same time destroying the financial future for many others.
Don’t get left behind. Get the facts for yourself